                         SEQUENCE LISTING

<110>  Neogenomics Laboratories, Inc.
 
<120>  HIGH-SENSITIVITY SEQUENCING TO DETECT BTK INHIBITOR RESISTANCE


<130>  NGNM.0008US/WO

<140>  
<141>  2016-08-17

<150>  62/206,248
<151>  2015-08-17

<150>  62/311,246
<151>  2016-03-21

<160>  12     

<170>  PatentIn version 3.5


<210>  1
<211>  35
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  1
tgtaaaacgg ccagtcagtt gtatggcgtc tgcac                               35


<210>  2
<211>  38
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  2
caggaaacag ctatgacctc caggtattcc atggcttc                            38


<210>  3
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<221>  oligomeric compound
<223>  BTK BNA (G+GA+G+G+C+A+G+C+CAT+TG-[phosphate])

<220>
<221>  misc_feature
<222>  2, 5, 7, 9, 11, 13, 15, 17, 21 
<223>  n= A, T, C or G

<400>  3
gngangngnc nangncncat ntg                                            23


<210>  4
<211>  34
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  4
tgtaaaacgg ccagtgctca cctggtcgtt ttcc                                34


<210>  5
<211>  38
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  5
caggaaacag ctatgaccca agcccctctg tagagcat                             38


<210>  6
<211>  17
<212>  DNA
<213>  Artificial Sequence

<220> 
<221>  oligomeric compound
<223>  PLCG2 LNA (+G+A+T+T+C+CC+C+G+G/3InvdT/)

<220>
<221>  misc_feature
<222>  1, 3, 5, 7, 9, 11, 14, 16 
<223>  n= A, T, C or G

<400>  6
ngnantntnc nccngng                                                     17

<210>  7
<211>  35 
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  7
tgtaaaacgg ccagtaaaaa ttgtttggcc accag                                 35


<210>  8
<211>  40
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  8
caggaaacag ctatgacctg gtgaatactc agaggtttgc                            40


<210>  9
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220> 
<221>  oligomeric compound
<223>  PLCG2 LNA (G+G+AC+C+T+C+CG+C+CT-[Phosphate])

<220>
<221>  misc_feature
<222>  2, 4, 7, 9, 11, 13, 16, 18 
<223>  n= A, T, C or G

<400>  9
gngnacncnt ncncgncnct                                                   20

<210>  10
<211>  35
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  10
tgtaaaacgg ccagtaaacg gtgtgctttg gaaac                                  35


<210>  11
<211>  38
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  11
caggaaacag ctatgaccag acaggaccct gtgtcagc                               38


<210>  12
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220> 
<221>  oligomeric compound
<223>  PLCG2 LNA (+C+T+T+A+G+G+G+T+C+TC/3InvdT/)

<220>
<221>  misc_feature
<222>  1, 3, 5, 7, 9, 11, 13, 15, 17, 19  
<223>  n= A, T, C or G

<400>  12
ncntntnang ngngntncnt c                                                     21

